American Journal of Public Health (11.03) Vol. 93; No. 11: 1897- 1903 - Tuesday, December 02, 2003
Susie Hoffman, DrPH; Theresa M. Exner, PhD; Cheng-Shiun Leu, PhD; Anke A. Ehrhardt, PhD: Zena Stein, MA, MB, BCh

The investigators found that relative to control subjects, women assigned to the 8-session group were more likely to report maintaining consistent safer sexual intercourse practices or decreasing the number of sexual intercourse occasions not protected by a male or female condom, at both the 1-month follow- up and the 12-month follow-up.

The researchers' findings demonstrate a short-term effect of intervention on female condom use. Women in the intervention groups assessed the female condom as more effective against STDs and pregnancy than women in the control group. Although women assigned to intervention groups were willing to try the female condom, that did not translate to sustained use.

"The intervention was the most important predictor of trying the female condom, but repeated use was related to women's comfort in using the female condom after trying it," according to the study. "In open-ended responses, 90 percent of women who found their first experience difficult cited problems with insertion."

Although the female condom has been touted as a method that can be used without a partner's support, the researchers found "several indications of male partners' influence on women's response to the female condom." They noted that other studies have also reported that men's reactions to the female condom are important predictors of women's use.

"From the studies of female-condom interventions conducted to date, we conclude that cognitive-behavioral interventions grounded in a gender-sensitive framework can increase women's ability to negotiate with their partners about female-condom use and promote first-time female-condom use. At present, however, the female condom seems to be difficult for women to adopt without more extensive trainings in its use," the authors concluded. "Our data suggest that interventions designed to offer women greater opportunities to become comfortable with insertion and to garner the support of male partners may be more effective in increasing long-term use. Public policy changes are warranted as well, including increased promotion and price support, especially now that some studies have shown that it is safe to reuse the female condom after washing. Without concurrent individual and structural interventions, the potential of the female condom to contribute to disease reduction will not be achieved."
031202
AD032493

Copyright © 2003 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .